AbstractAlthough controversial, recent studies suggest that serous ovarian carcinomas may arise from fallopian tube fimbria rather than ovarian surface epithelium. We developed an in vitro model for serous carcinogenesis in which primary human fallopian tube epithelial cells (FTECs) were exposed to potentially oncogenic molecular alterations delivered by retroviral vectors. To more closely mirror in vivo conditions, transformation of FTECs was driven by the positive selection of growth-promoting alterations rather antibiotic selection. Injection of the transformed FTEC lines in SCID mice resulted in xenografts with histologic and immunohistochemical features indistinguishable from poorly differentiated serous carcinomas. Transcriptional pro...
Epithelial ovarian cancer is the second most common gynaecological cancer, but has the highest fatal...
Germline or somatic mutation(s) in BRCA1 is associated with a 40-50% lifetime risk of developing hig...
Epithelial ovarian cancer is the second most common gynaecological cancer, but has the highest fatal...
AbstractAlthough controversial, recent studies suggest that serous ovarian carcinomas may arise from...
Although controversial, recent studies suggest that serous ovarian carcinomas may arise from fallopi...
SummaryHigh-grade serous ovarian carcinoma presents significant clinical and therapeutic challenges....
SummaryHigh-grade serous ovarian carcinoma presents significant clinical and therapeutic challenges....
Recent studies have suggested that the most common and lethal type of ‘ovarian’ cancer, i.e. high‐gr...
High grade serous ovarian cancer (HGSC), the most lethal and frequent type of epithelial ovarian can...
Recent evidence suggests that ovarian high-grade serous carcinoma (HGSC) originates from the epithel...
High-grade serous ovarian cancer, also known as high-grade serous carcinoma (HGSC), is the most comm...
Ovarian cancer is the sixth most lethal cancer in women. Out of all ovarian cancers – the high grade...
Ovarian cancer is the sixth most lethal cancer in women. Out of all ovarian cancers – the high grade...
Epithelial ovarian carcinoma accounts for 90% of all ovarian cancer and is the most deadly gynecolog...
High-grade serous cancer (HGSC) progresses to advanced stages without symptoms and the 5-year surviv...
Epithelial ovarian cancer is the second most common gynaecological cancer, but has the highest fatal...
Germline or somatic mutation(s) in BRCA1 is associated with a 40-50% lifetime risk of developing hig...
Epithelial ovarian cancer is the second most common gynaecological cancer, but has the highest fatal...
AbstractAlthough controversial, recent studies suggest that serous ovarian carcinomas may arise from...
Although controversial, recent studies suggest that serous ovarian carcinomas may arise from fallopi...
SummaryHigh-grade serous ovarian carcinoma presents significant clinical and therapeutic challenges....
SummaryHigh-grade serous ovarian carcinoma presents significant clinical and therapeutic challenges....
Recent studies have suggested that the most common and lethal type of ‘ovarian’ cancer, i.e. high‐gr...
High grade serous ovarian cancer (HGSC), the most lethal and frequent type of epithelial ovarian can...
Recent evidence suggests that ovarian high-grade serous carcinoma (HGSC) originates from the epithel...
High-grade serous ovarian cancer, also known as high-grade serous carcinoma (HGSC), is the most comm...
Ovarian cancer is the sixth most lethal cancer in women. Out of all ovarian cancers – the high grade...
Ovarian cancer is the sixth most lethal cancer in women. Out of all ovarian cancers – the high grade...
Epithelial ovarian carcinoma accounts for 90% of all ovarian cancer and is the most deadly gynecolog...
High-grade serous cancer (HGSC) progresses to advanced stages without symptoms and the 5-year surviv...
Epithelial ovarian cancer is the second most common gynaecological cancer, but has the highest fatal...
Germline or somatic mutation(s) in BRCA1 is associated with a 40-50% lifetime risk of developing hig...
Epithelial ovarian cancer is the second most common gynaecological cancer, but has the highest fatal...